Steve Schonfeld’s Translational Development Acquisition Corp TDAC Stock Holding History

Steve Schonfeld’s Portfolio TDAC Stock Details TDAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Sell	98,630 -51,371	-34%	-$549K	﹤0.01%	1447
2026 Q1	$1.59M	Buy	150,001 +15,187	+11%	+$160K	0.01%	913
2025 Q4	$1.41M	Hold	134,814	–	–	0.01%	985
2025 Q3	$1.4M	Sell	134,814 -10,186	-7%	-$105K	0.01%	1216
2025 Q2	$1.49M	Buy	145,000 +18,039	+14%	+$183K	0.01%	1129
2025 Q1	$1.28M	Buy	+126,961	New	+$1.28M	0.01%	1178

Other funds holding TDAC

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

Steve Schonfeld's TDAC Position: Q2 2026 in Review

Steve Schonfeld reduced its Translational Development Acquisition Corp (TDAC) stake by 34% in Q2 2026, selling an estimated $549K and leaving 98,630 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

Steve Schonfeld first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.59M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

Steve Schonfeld held 98,630 shares of Translational Development Acquisition Corp worth $1.05M as of Q2 2026.
Steve Schonfeld sold 51,371 Translational Development Acquisition Corp shares in Q2 2026, an estimated $549K.
Translational Development Acquisition Corp made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1447 holding.
Steve Schonfeld first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
Steve Schonfeld's Translational Development Acquisition Corp position peaked at $1.59M in Q1 2026.
35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.